Skip to main content

Day: April 22, 2021

Wolters Kluwer Annual General Meeting of Shareholders adopts all resolutions

Wolters Kluwer Annual General Meeting of Shareholders adopts all resolutions April 22, 2021 – Wolters Kluwer, a global provider of professional information, software solutions, and services, is pleased to announce that all resolutions were adopted as proposed at today’s Annual General Meeting. Reappointment of members of the Supervisory Board and member of the Executive BoardFrans Cremers and Ann Ziegler were reappointed as members of the Supervisory Board and Kevin Entricken was reappointed as member of the Executive Board. The Supervisory Board members represent a diversity of nationality, experience, talent, and expertise. Three (43%) of the seven Supervisory Board members are female, in line with Dutch corporate governance standards and proposed legislation. 2020 Financial Statements and dividendShareholders voted to adopt the Financial...

Continue reading

STMicroelectronics rejoint la mioty® Alliance, élargissant le déploiement d’applications pour l’IoT massif

T4348S STMicroelectronics rejoint la mioty®Alliance, élargissant le déploiement d’applications pour l’IoT massif La pile de protocole mioty développée par Stackforce, partenaire agréé de ST, est désormais disponible pour le système sur puce sans fil multi–modulations STM32WL Genève (Suisse), le 22 avril 2021 — STMicroelectronics (NYSE : STM), un leader mondial des semiconducteurs dont les clients couvrent toute la gamme des applications électroniques, inspire la nouvelle génération d’applications pour l’IoT massif qui privilégient l’évolutivité à la rapidité, avec la prise en charge du standard mioty® pour l’établissement de connexions sans fil longue portée, extrêmement économes en énergie et hautement évolutives. Parallèlement à son adhésion à l’Alliance mioty, impliquée dans la promotion et les spécifications de la technologie,...

Continue reading

ArcAroma AB: 210422 Aktierna i ArcAroma avnoteras och sista dagen för handel är den 18 maj 2021

ArcAroma AB (publ) (”ArcAroma”) har genom pressmeddelande den 20 april 2021 kommunicerat att ArcAroma, som ett led i pågående fusion mellan OptiFreeze AB (publ) och ArcAroma, har ansökt om avnotering av bolagets aktie från Nasdaq First North Premier Growth Market segment. Nasdaq Stockholm AB har beslutat att godkänna ArcAromas ansökan om avnotering av aktierna i ArcAroma samt beslutat, under förutsättning av att Bolagsverket den 18 maj 2021 lämnar tillstånd att verkställa fusionen mellan OptiFreeze AB (publ) och ArcAroma, att sista dag för handel ska vara den 18 maj 2021. Informationen lämnades, genom nedanstående kontaktpersons försorg, för offentliggörande den 22 april 2021 klockan 16:45 CEST. För ytterligare information, vänligen kontakta: Peter Ahlgren, styrelseordförande ArcAroma AB (publ)E-post: peter.ahlgren@arcaroma.comTelefon:...

Continue reading

Apria Healthcare Collaborates with Rackspace Technology to Leave the Data Center Resulting in Improved Customer Experience and Increased Savings

SAN ANTONIO, April 22, 2021 (GLOBE NEWSWIRE) — Rackspace Technology (NASDAQ: RXT), an end-to-end multicloud technology solutions company, today announced a collaboration with Apria Healthcare, a provider of home respiratory services and related medical equipment, to modernize its legacy IT infrastructure resulting in a 32% reduction in operating costs. Apria Healthcare collaborated with Rackspace Technology to manage, modernize and secure its data center by consolidating and collocating its existing infrastructure by leveraging Rackspace Professional Services for Amazon Web Services (AWS), Rackspace Private Cloud powered by VMware and Managed AWS infrastructure. The move to the new infrastructure resulted in efficiencies, savings, and bolstered their online storefronts with managed hosting during the peak buying season. “Part of...

Continue reading

Amarin Receives Great Britain Marketing Authorization for VAZKEPA from the Medicines and Healthcare Products Regulatory Agency (MHRA) 1,2

VAZKEPA (icosapent ethyl) is the first and only authorized treatment for its cardiovascular risk reduction indication1,2,3 VAZKEPA authorization for Great Britain follows recent VAZKEPA authorization for European Union DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a Marketing Authorization for VAZKEPA (icosapent ethyl) as a treatment to reduce the risk of cardiovascular events in high cardiovascular risk statin-treated adult patients who have elevated triglycerides (≥150 mg/dL) and either established cardiovascular disease or diabetes, and at least one additional cardiovascular risk factor. The Great Britain Marketing Authorization for VAZKEPA applies to England, Scotland...

Continue reading

AUGA group, AB progresses with its employee motivation scheme through share options

The organic producer AUGA group, AB (hereinafter the Company) is progressing with its employee motivation scheme through share options. The Company has made a decision to allocate a further 2.5 million shares to the employees and members of management bodies of the Company and its subsidiaries (hereinafter Employees). In total, since 2019 the Company will have allocated 7.2 million shares to its Employees. It also plans to assign a further more than 3 million shares for the same purpose in the future. The Company launched its first option programme in spring 2019. Almost 2.55 million shares were allocated to Employees in the first stage and additional 2.23 million shares in 2020. The programme is being continued this year, with the allocation of a further 2.5 million shares. A motion to approve an additional 1.7 million shares for future...

Continue reading

AUGA group, AB tęsia darbuotojų skatinimo akcijomis programą

Ekologiškų produktų gamintoja AUGA group, AB (toliau – Bendrovė) tęsia pradėtą opcionų programą. Bendrovė nusprendė savo ir jos dukterinių įmonių darbuotojams ir valdymo organų nariams (toliau – Darbuotojai) paskirstyti 2,5 mln. vnt. akcijų. Viso nuo akcijų opcionų programos pradžios 2019 m. Darbuotojams Bendrovė bus paskirsčiusi 7,2 mln. vnt. akcijų. Ateityje opcionų programai ketinama skirti dar daugiau kaip 3 mln. vnt. akcijų. Opcionų programą Bendrovė pradėjo 2019 metų pavasarį. Tuomet pirmuoju etapu Darbuotojams buvo paskirta beveik 2,55 mln. vnt. akcijų, 2020 m. – 2,23 mln. vnt. akcijų. Šiemet tęsiant programą Darbuotojams vėl buvo paskirstyta 2,5 mln. vnt. akcijų. Bendrovės eiliniam visuotiniam akcininkų susirinkimui siūloma patvirtinti projektą, pagal kurį šiai programai ateityje būtų papildomai skirta 1,7 mln. vnt. akcijų...

Continue reading

Transfer of Huhtamäki Oyj’s own treasury shares

HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 22.4.2021 AT 17:50 Transfer of Huhtamäki Oyj’s own treasury shares A total of 15,000 of Huhtamäki Oyj’s own treasury shares have today been transferred without consideration to the Company’s President and CEO Charles Héaulmé as part of his remuneration. The directed issue is based on the authorization given by the Company’s Annual General Meeting of 2021 and the decision by the Company’s Board of Directors based on the authorization. After the transfer, Huhtamäki Oyj holds a total of 3,395,709 own treasury shares (3.15% of all shares). For further information, please contact:Mr. Sami Pauni, Executive Vice President, Corporate Affairs and Legal, Group General Counsel, tel. +358 (0)10 686 7872 HUHTAMÄKI OYJGlobal Communications About HuhtamakiHuhtamaki is a key global provider...

Continue reading

Huhtamäki Oyj:n omien osakkeiden luovutus

HUHTAMÄKI OYJ PÖRSSITIEDOTE 22.4.2021 KLO 17.50 Huhtamäki Oyj:n omien osakkeiden luovutus Yhteensä 15 000 Huhtamäki Oyj:n omaa osaketta on tänään luovutettu vastikkeetta yhtiön toimitusjohtajalle Charles Héaulmélle osana hänen palkitsemistaan. Suunnattu anti perustuu yhtiön vuoden 2021 varsinaisen yhtiökokouksen antamaan valtuutukseen ja yhtiön hallituksen valtuutuksen perusteella tekemään päätökseen. Luovutuksen jälkeen Huhtamäki Oyj omistaa yhteensä 3 395 709 omaa osaketta (3,15 % kaikista osakkeista). Lisätietoja:Sami Pauni, hallinto- ja lakiasiainjohtaja, puh. 010 686 7872 HUHTAMÄKI OYJKonserniviestintä Tietoja HuhtamäestäHuhtamäki on maailmanlaajuisesti johtava vastuullisten pakkausratkaisujen toimittaja, joka mahdollistaa hyvinvointia ja sujuvaa arkea kuluttajille ympäri maailmaa. Innovatiiviset tuotteemme suojaavat noutoruokaa...

Continue reading

Information on the Availability of the 2020 Universal Registration Document

REGULATED INFORMATION MAISONS DU MONDE: INFORMATION ON THE AVAILABILITY OF THE 2020 UNIVERSAL REGISTRATION DOCUMENT Nantes – 22 April 2021 – Maisons du Monde (Euronext Paris: MDM, ISIN Code: FR0013153541), announces the release of its 2020 Universal Registration Document. The 2020 Universal Registration Document was filed with the Autorité des Marchés Financiers (AMF) on 22 April 2021, in ESEF format and under number D.21-0340. The French version of this document is available to the public free of charge under the conditions set out by the regulations in force, and on the company’s website at :https://corporate.maisonsdumonde.com/en/finance/financial-reports , as well as on the AMF’s website :https://www.amf-france.org/en. The English version will be available as of 27 April 2021. The 2020 Universal Registration Document includes,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.